• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Geriatr . Risk factors for 30-day COVID-19 mortality among people living with dementia in Alberta, Canada: a retrospective cohort study

tetano

Editor, Senior Moderator
BMC Geriatr


. 2025 Sep 29;25(1):745.
doi: 10.1186/s12877-025-06448-w. Risk factors for 30-day COVID-19 mortality among people living with dementia in Alberta, Canada: a retrospective cohort study

Maya Goerzen[SUP] 1 [/SUP], Andrea Gruneir[SUP] 2 [/SUP], Deniz Cetin-Sahin[SUP] 3 [/SUP], Claire Godard-Sebillotte[SUP] 4 5 [/SUP], Eric Smith[SUP] 6 [/SUP], Pamela Roach[SUP] 7 [/SUP], Julia Kirkham[SUP] 1 [/SUP], Dallas Seitz[SUP] 8 9 [/SUP]



Affiliations
Abstract

Background: People living with dementia (PLWD) were disproportionately impacted by the COVID-19 pandemic, experiencing high mortality rates in the initial waves. However, factors contributing to their increased risk of death following COVID-19 infection remain unclear. Given that PLWD are a heterogenous population with varying susceptibility to negative health outcomes, this study aimed to identify independent factors associated with 30-day COVID-19 mortality among PLWD and vulnerable subgroups of PLWD.
Methods: We conducted a retrospective cohort analysis using administrative data from March 1st 2020 to December 1st 2020, in Alberta, Canada. We examined the association between an outcome variable created to examine mortality in the 30-days following COVID-19 infection and factors related to the demographics and health (e.g., age, comorbidities), health service use (e.g., past physician utilization), and environment (e.g., community or long-term care) of PLWD in our study cohort and subgroups of our study cohort based on age, sex, and living setting (community, long-term care).
Results: Among our study cohort of PLWD (N = 1526), 28% of individuals died within 30 days following COVID-19 infection. After adjusting for confounders, increasing age (AOR = 2.38, 95% CI: 1.12-5.06), male sex (AOR = 2.30, 95% CI: 1.76-3.01), and living in long-term care (AOR = 5.91, 95% CI: 4.49-7.79) were associated with a higher risk of 30-day COVID-19 mortality. Additionally, congestive heart failure, diabetes with complications, and renal failure were linked to mortality among certain subgroups of PLWD.
Conclusions: The 30-day COVID-19 case fatality rate was high among PLWD. PLWD who were older, male, and living in long-term care were at the greatest risk. The findings of this study demonstrate that specific groups of PLWD, based on both demographic and site-of-care-related factors, would benefit most from improved attention in future infectious disease public health planning.

Keywords: COVID-19; Dementia; Long-term care; Mortality.

 
Back
Top Bottom